SCHEMBL6917185

SCHEMBL6917185

O=C1C=CC(O)(O)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.52
CDC25B P30305 3/20 0.52
EHMT2 Q96KQ7 2/20 0.52
PIN1 Q13526 2/20 0.52
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
AKT1 P31749 1/20 0.52
SNCA P37840 1/20 0.52
MAP2K1 Q02750 1/20 0.52
NSD1 Q96L73 1/20 0.52
EHMT1 Q9H9B1 1/20 0.52
ALDH1A1 P00352 6/20 0.44
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 2/20 0.44
RECQL P46063 3/20 0.41
MAPK1 P28482 2/20 0.41
CASP1 P29466 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9861418 0.76 PDK2 (0.48) IDO1CDC25BEHMT2PIN1MAOA
SCHEMBL13508801 0.76 CDC25B (0.43) IDO1CDC25BEHMT2PIN1MAOA
SCHEMBL30229349 0.75 IDO1 (0.46) IDO1CDC25BEHMT2PIN1MAOA
Naphthoquinone SCHEMBL42139 0.71 IDO1 (1.00) IDO1CDC25BEHMT2PIN1MAOA
Naphthoquinone SCHEMBL11359780 0.71 IDO1 (1.00) IDO1CDC25BEHMT2PIN1MAOA
Naphthoquinone SCHEMBL8861335 0.71 IDO1 (1.00) IDO1CDC25BEHMT2PIN1MAOA
Naphthoquinone SCHEMBL29354680 0.71 IDO1 (1.00) IDO1CDC25BEHMT2PIN1MAOA
SCHEMBL3673372 0.71 CDC25B (0.41) IDO1CDC25BEHMT2PIN1MAOA
Naphthoquinone SCHEMBL27807119 0.69 CDC25B (0.82) IDO1CDC25BEHMT2PIN1MAOA
Naphthoquinone SCHEMBL27995889 0.69 CDC25B (0.82) IDO1CDC25BEHMT2PIN1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673937-B2 ANALOGS OF DEOXYPREUSSOMERIN, PALMARUMYCIN CPI AND RELATED NAPHTHOQUINONE SPIROKETALS; INHIBIT THIOREDOXIN-THIOREDOXIN REDUCTASE SYSTEM THE UNIVERSITY OF PITTSBURGH 2004-01-06 US disclosed
US-20020049221-A1 Synthesis and methods of use of new antimitotic agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049221-A1 Synthesis and methods of use of new antimitotic agents TXNRD1, TXNRD3, TXN2 IDO1 4538/4885CDC25B 765/4885EHMT2 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.